Next Article in Journal
IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway
Next Article in Special Issue
Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients
Previous Article in Journal
Biphasic Effects of Blue Light Irradiation on Human Umbilical Vein Endothelial Cells
Previous Article in Special Issue
Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
 
 
Article
Peer-Review Record

Pulmonary MicroRNA Changes Alter Angiogenesis in Chronic Obstructive Pulmonary Disease and Lung Cancer

Biomedicines 2021, 9(7), 830; https://doi.org/10.3390/biomedicines9070830
by Clara E. Green 1,*, Joseph Clarke 2, Roy Bicknell 2 and Alice M. Turner 3
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomedicines 2021, 9(7), 830; https://doi.org/10.3390/biomedicines9070830
Submission received: 8 June 2021 / Revised: 5 July 2021 / Accepted: 7 July 2021 / Published: 16 July 2021

Round 1

Reviewer 1 Report

The Authors presented original data on the differential expression of a set of microRNAs in human pulmonary endothelial cells freshly isolated from lung tissues of lung cancer patients affected or not by COPD. They also demonstrate the functional role of miRNAs in a model of endothelial cells derived from umbelical vein (HUVEC). Representative images of HPEC should be shown    in figure 1. The abstract should state that functional assays were performed using the HUVEC  cell line model.

 

Author Response

The Authors presented original data on the differential expression of a set of microRNAs in human pulmonary endothelial cells freshly isolated from lung tissues of lung cancer patients affected or not by COPD. They also demonstrate the functional role of miRNAs in a model of endothelial cells derived from umbelical vein (HUVEC).

Representative images of HPEC should be shown in figure 1.

Thank you – we have done this.

The abstract should state that functional assays were performed using the HUVEC cell line model.

Thank you for your comment. We have altered the abstract to include this.

Author Response File: Author Response.docx

Reviewer 2 Report

An interesting and novel work. The small size of subjects is indeed a limitation as it has already been said by the authors. More tissue samples are at need for more conclusions.

Could you elaborate upon any other methods or results to be compared such as any immunocytochemistry procedures? Why did you prefer this method?

Also, discussion section should be in full and not seperated.

Author Response

Could you elaborate upon any other methods or results to be compared such as any immunocytochemistry procedures? Why did you prefer this method?

Thank you for your comment. We decided to focus on cell culture models rather than immunohistochemistry as the optimal way of investigating microRNA function as opposed to comparing microRNA expression between groups which had been investigated in the microarray and qPCR experiments. We focused on cell culture methods that had previously been used and published in previous works of endothelial function as these methods have previously been validated. Previous examples of work using similar methods include the following (these are also referenced in the text):

Zhuang, X., et al., Br J Cancer, 2015. 112(3): p. 485-94.

Noy, P.J., et al., Oncogene, 2015. 34(47): p. 5821-31.

Munir, H., et al., J Vis Exp, 2015(95): p. e52480.

Also, discussion section should be in full and not separated.

Thank you – we have made this alteration.

Author Response File: Author Response.docx

Back to TopTop